Related Experiment Videos
Autologous glutaraldehyde-treated pericardial valved conduit: an experimental study
M N Kumar1, G Prabakar, N Kumar
1Department of Cardiovascular Diseases, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
The Annals of Thoracic Surgery
|August 1, 1995
Summary
Researchers developed a new valved conduit from treated animal tissue to address limitations of current options for ventricular outflow tract reconstruction. This innovative approach showed promising results in sheep, avoiding calcification and neointimal peel after nine months.
Area of Science:
- Cardiovascular Surgery
- Biomaterials Science
- Regenerative Medicine
Background:
- Extracardiac conduits (allografts, synthetic tubes with heterograft valves) are used for ventricular outflow tract abnormalities.
- Current conduits face limitations like long-term calcification and neointimal peel, often requiring reoperation.
- There is a need for improved, durable alternatives for ventriculoarterial continuity.
Purpose of the Study:
- To design and evaluate a novel valved sinus-bearing conduit using autologous pericardium treated with glutaraldehyde.
- To assess the long-term performance and biocompatibility of this new conduit in a preclinical model.
Main Methods:
- A valved sinus-bearing conduit was constructed from glutaraldehyde-treated autologous pericardium.
- The conduit's construction methodology is detailed.
- Implantation was performed in 12 sheep, with follow-up assessments.
Main Results:
- No progression of gradients was observed post-implantation.
- No evidence of fresh regurgitation was detected.
- No wall or cusp calcification was found at 9 months after implantation.
Conclusions:
- Autologous pericardium treated with glutaraldehyde can be fashioned into a functional valved conduit.
- This novel conduit demonstrates excellent biocompatibility and durability in a sheep model.
- It presents a promising alternative to current extracardiac conduits, potentially reducing reoperation rates.